Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)-Reference-Cited by-同舟云学术

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

Published:2017-09-14 Issue:11 Volume:130 Page:1377-1380
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Cohen Aubart Fleur¹²,Emile Jean-François³⁴,Carrat Fabrice²⁵⁶,Charlotte Frédéric²⁷,Benameur Neila⁸,Donadieu Jean⁹,Maksud Philippe¹⁰,Idbaih Ahmed¹¹,Barete Stéphane¹²,Hoang-Xuan Khê¹¹,Amoura Zahir¹²,Haroche Julien¹²

Affiliation:

1. Department of Internal Medicine 2, Assistance Publique–Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French National Centre for Rare Systemic Diseases, Paris, France;

2. Paris VI University, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France;

3. EA4340, Versailles University, Versailles, France;

4. Department of Pathology, AP-HP, Ambroise Paré Hospital, Boulogne, France;

5. INSERM Unit 1136, Pierre-Louis Institute of Epidemiology and Public Health, Paris, France;

6. Department of Public Health, AP-HP, Saint-Antoine Hospital, Paris, France;

7. Department of Pathology and

8. Department of Pharmacy, AP-HP, Pitié-Salpêtrière Hospital, Paris, France;

9. Department of Haematology, AP-HP, Trousseau Hospital, Paris, France; and

10. Department of Nuclear Medicine,

11. Department of Neurology, and

12. Dermatology Unit, AP-HP, Pitié-Salpêtrière Hospital, Paris, France

Publisher